My NCBISign In

Display Settings:

Format

Send to:

Choose Destination

    Vaccine. 2001 Aug 14;19(31):4409-16.

    Passive transfer of protection against Bacillus anthracis infection in a murine model.

    Beedham RJ, Turnbull PC, Williamson ED.

    Pathobiology, CBD, DERA Porton Down, Salisbury, SP4 0JQ, Wiltshire, UK.

    Abstract

    Passive transfer of lymphocytes and sera from mice immunised using two different formulations containing recombinant protective antigen (rPA) have been used to further elucidate the mechanism of protection against Bacillus anthracis infection. The results demonstrated that an antibody response maybe important in protection against B. anthracis infection, under the conditions tested. The results provide further data for the development of an improved anthrax vaccine.

    PMID: 11483266 [PubMed - indexed for MEDLINE]

    Supplemental Content

    Click here to read

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...
    Write to the Help Desk